Table 3.
Results of susceptibility testing on isolates cultured from patients with nosocomial infection at Imam Reza Hospital
| Antibiotic | Sensitive | Semi-Sensitive | Resistance | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | Number | % | |
| Amikacin | 55 | 51.4% | 16 | 15.0% | 36 | 33.6% | 107 | 100.0% |
| Ceftriaxon | 14 | 23.7% | 7 | 11.9% | 38 | 64.4% | 59 | 100.0% |
| Cephtazideme | 22 | 22.2% | 15 | 15.2% | 62 | 62.6% | 99 | 100.0% |
| Cefepime | 16 | 13.4% | 11 | 9.2% | 92 | 77.3% | 119 | 100.0% |
| Cefixime | 3 | 4.4% | 4 | 5.9% | 61 | 89.7% | 68 | 100.0% |
| Ciprofloxacin | 79 | 63.2% | 7 | 5.6% | 39 | 31.2% | 125 | 100.0% |
| Gentamicin | 47 | 37.0% | 11 | 8.7% | 69 | 54.3% | 127 | 100.0% |
| Meropenem | 7 | 8.1% | 3 | 3.5% | 76 | 88.4% | 86 | 100.0% |
| Piperacillin | 55 | 47.8% | 13 | 11.3% | 47 | 40.9% | 115 | 100.0% |
| Tetracyclin | 9 | 22.5% | 5 | 12.5% | 26 | 60.0% | 40 | 100.0% |
| Imipenem | 61 | 46.9% | 6 | 4.6% | 63 | 48.5% | 130 | 100.0% |
| Carbenicillin | 1 | 25.0% | 0 | .0% | 3 | 75.0% | 4 | 100.0% |
| Tobramycin | 0 | .0% | 0 | .0% | 2 | 100.0% | 2 | 100.0% |
| Colistin | 61 | 78.2% | 17 | 21.8% | 0 | .0% | 78 | 100.0% |